Related Experiment Videos
Roundtable of Experts in Surgery Blood Management--consensus statement
1Institut für Chirurgische Forschung, Klinikum Grosshadern, Ludwig-Maximilians-Universität München, Germany.
Infusionstherapie Und Transfusionsmedizin
|June 1, 1996
Summary
Epoetin alfa therapy offers practical guidelines for elective surgery patients, reducing risks associated with allogeneic blood transfusions. This approach particularly benefits patients with smaller body size or low blood volume undergoing autologous blood donation.
Area of Science:
- Surgical Blood Management
- Anesthesiology
- Hematology
Background:
- Allogeneic blood transfusions carry inherent risks.
- Blood conservation methods are crucial in elective surgery.
- Epoetin alfa is an adjunctive therapy for specific surgical patients.
Framework:
- Consensus statement developed from expert roundtable discussion.
- Review of published and unpublished epoetin alfa clinical data.
- Practical guidelines for clinicians administering epoetin alfa.
Implementation:
- Epoetin alfa therapy aims to eliminate or reduce allogeneic blood exposure.
- Identifies specific patient subgroups benefiting from epoetin alfa.
- Addresses patients with small body size, low predicted blood volume (< or = 51), or insufficient hematocrit for autologous blood donation (ABD).
Implications:
- Epoetin alfa provides a viable blood conservation strategy.
- Demonstrates an acceptable risk-to-benefit ratio for targeted patient populations.
- Supports informed clinical decision-making in perioperative blood management.